Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.

Bauriaud-Mallet M, Vija-Racaru L, Brillouet S, Mallinger A, de Medina P, Rives A, Payre B, Poirot M, Courbon F, Silvente-Poirot S.

J Steroid Biochem Mol Biol. 2019 Sep;192:105390. doi: 10.1016/j.jsbmb.2019.105390. Epub 2019 Jun 3.

PMID:
31170473
2.

Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.

Vija Racaru L, Sinigaglia M, Kanoun S, Ben Bouallègue F, Tal I, Brillouet S, Bauriaud-Mallet M, Zerdoud S, Dierickx L, Vallot D, Caselles O, Gabiache E, Pascal P, Courbon F.

Nucl Med Commun. 2018 Jul;39(7):672-679. doi: 10.1097/MNM.0000000000000850.

3.

Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders: real life experience and predictive factors of functional response.

Vija Racaru L, Fontan C, Bauriaud-Mallet M, Brillouet S, Caselles O, Zerdoud S, Bastié D, Vallot D, Caron P, Bardiès M, Courbon F.

Nucl Med Commun. 2017 Sep;38(9):756-763. doi: 10.1097/MNM.0000000000000705.

PMID:
28719405
4.

Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer.

Dierickx LO, Dercle L, Chaltiel L, Caselles O, Brillouet S, Zerdoud S, Courbon F.

Q J Nucl Med Mol Imaging. 2019 Sep;63(3):284-291. doi: 10.23736/S1824-4785.17.02912-0. Epub 2017 Mar 29.

PMID:
28358186
5.

Comparison of an alternative and existing binning methods to reduce the acquisition duration of 4D PET/CT.

Didierlaurent D, Jaudet C, Ribes S, Batatia H, Dierickx LO, Zerdoud S, Brillouet S, Weyts K, Courbon F, Caselles O.

Med Phys. 2014 Nov;41(11):112503. doi: 10.1118/1.4897612.

PMID:
25370662
6.

The retrospective binning method improves the consistency of phase binning in respiratory-gated PET/CT.

Didierlaurent D, Ribes S, Batatia H, Jaudet C, Dierickx LO, Zerdoud S, Brillouet S, Caselles O, Courbon F.

Phys Med Biol. 2012 Dec 7;57(23):7829-41. doi: 10.1088/0031-9155/57/23/7829. Epub 2012 Nov 8.

PMID:
23135238
7.

Functional testicular evaluation using PET/CT with 18F-fluorodeoxyglucose.

Dierickx LO, Huyghe E, Nogueira D, Zerdoud S, Filleron T, Brillouet S, Delauney B, Montagut J, Bujan L, Plante P, Courbon F.

Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):129-37. doi: 10.1007/s00259-011-1929-3. Epub 2011 Sep 10.

PMID:
21909754
8.

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.

de Medina P, Paillasse MR, Ségala G, Khallouki F, Brillouet S, Dalenc F, Courbon F, Record M, Poirot M, Silvente-Poirot S.

Chem Phys Lipids. 2011 Sep;164(6):432-7. doi: 10.1016/j.chemphyslip.2011.05.005. Epub 2011 May 27. Review.

PMID:
21641337
9.

Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.

Vergez S, Delord JP, Thomas F, Rochaix P, Caselles O, Filleron T, Brillouet S, Canal P, Courbon F, Allal BC.

Clin Cancer Res. 2010 Sep 1;16(17):4434-45. doi: 10.1158/1078-0432.CCR-09-2795. Epub 2010 Jul 26.

10.

Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.

Brillouet S, Dorbes S, Courbon F, Picard C, Delord JP, Benoist E, Poirot M, Mestre-Voegtlé B, Silvente-Poirot S.

Bioorg Med Chem. 2010 Jul 15;18(14):5400-12. doi: 10.1016/j.bmc.2010.05.031. Epub 2010 May 19.

PMID:
20542702

Supplemental Content

Loading ...
Support Center